Notice of Intent to Sole Source - ChromoLogic
ID: HCCCC-2025-00493Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

All Other Professional, Scientific, and Technical Services (541990)

PSC

GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH (AJ12)
Timeline
  1. 1
    Posted Dec 30, 2024, 12:00 AM UTC
  2. 2
    Updated Dec 30, 2024, 12:00 AM UTC
  3. 3
    Due Jan 8, 2025, 2:00 PM UTC
Description

The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking a vendor for a sole-source contract to evaluate test samples from rats exposed to silica-containing engineered stone dusts. The primary objective is to collaborate with the vendor to develop predictive algorithms for pre-symptomatic pulmonary fibrosis, utilizing their proprietary algorithms to assess the effectiveness of existing predictive models for radiation-induced pulmonary fibrosis in the context of silica-induced fibrosis. This initiative is critical for advancing research in pulmonary health and understanding the impacts of silica exposure, with the vendor responsible for miRNA extraction, sequencing, and bioinformatic analysis of the samples. Interested parties can contact Kathryn Green at ezj7@cdc.gov or by phone at 404-639-6470 for further details.

Point(s) of Contact
Files
Title
Posted
Dec 30, 2024, 6:05 PM UTC
Lifecycle
Title
Type
Combined Synopsis/Solicitation
Similar Opportunities
Serological Assays for the Detection and Characterization of Influenza Viruses
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is soliciting proposals for a contract to provide serological assays for the detection and characterization of influenza viruses. The primary objective of this procurement is to support the CDC's Influenza Division by conducting hemagglutination inhibition assays on approximately 6,000 human serum samples annually and developing new serology platforms to enhance testing capabilities. This contract is critical for improving influenza surveillance and vaccine effectiveness studies, ensuring timely and accurate public health responses. Interested vendors should note that the new ship date for assays is March 31, 2025, with results due by April 15, 2025, and can contact Jennifer Gartzke at jgartzke@cdc.gov or 404-498-0020 for further information.
Solicitation - World Trade Center Health Program - Survivor Clinical Center of Excellence
Buyer not available
The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), is soliciting proposals for the Survivor Clinical Center of Excellence (CCE) under Solicitation 75D301-25-R-00088. The objective is to procure healthcare services for eligible survivors of the September 11, 2001, terrorist attacks, focusing on health monitoring, diagnosis, and treatment for individuals residing in the New York Metropolitan Area. This initiative is critical for providing ongoing medical support to a population significantly impacted by the attacks, ensuring they receive necessary care and resources. Interested contractors must submit their proposals electronically, adhering to the outlined requirements and deadlines, with questions directed to the primary contacts, Serina Allingham at xog9@cdc.gov or Patrick Winders at vxx6@cdc.gov.
World Trade Center Health Program - Outreach and Education
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking contractors for the World Trade Center (WTC) Health Program's Outreach and Education initiative. The objective is to implement targeted outreach, education, and support services for 9/11 survivors and responders, enhancing awareness and access to health benefits related to their exposure to the September 11 attacks. This program is crucial for addressing the long-term health impacts on approximately 400,000 affected individuals, with current enrollment at only 34%. The solicitation number for this opportunity is 75D30125Q00092, and the contract is expected to span from June 15, 2025, to June 14, 2030, with the potential for multiple awards. Interested parties should contact Joseph Jones at zjb2@cdc.gov for further details and to ensure compliance with submission requirements.
Custom Labels Requirement
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking to procure custom labeling materials through a sole-source contract with Multisystems Inc. This procurement involves specialized RM 66171 Clear PolyPro labels and Thermal Transfer Ribbon Wax/Resin, which are essential for labeling specimen tubes that must endure extremely low temperatures. The labels are critical for the CDC's dengue research specimen handling and must meet specific requirements, including compatibility with the ZT 230 Printer and compliance with CLIA regulations. Interested parties are encouraged to express their capability to fulfill these requirements by April 4, 2025, and should contact Ashley Williams at dal3@cdc.gov or Sheena Delaine at kpz5@cdc.gov for further information.
NULISAseq CNS Disease Panel 120 Kit or Equivalent
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information from qualified sources regarding the availability of the Alamar NULISAseq CNS Disease Panel 120 Kit or equivalent products. The objective is to procure three kits to aid in the investigation of biomarkers for neurodegenerative diseases, which are critical for early diagnosis and potential preventive measures. This procurement is essential for the NIH's Laboratory of Clinical Investigation, which focuses on isolating and measuring biomarkers from patient plasma to improve disease detection and management. Interested companies must submit their capability statements by April 11, 2025, to Eric McKay at eric.mckay@nih.gov, ensuring they include relevant details such as their business type and manufacturing information.
AJ12--Sources Sought Mouse Surveillance & Testing
Buyer not available
The Department of Veterans Affairs is seeking capable vendors for a Rodent Health Surveillance Monitoring and Testing Program through a Sources Sought Notice. This initiative aims to diagnose, treat, and control diseases in research rodent colonies by conducting tests for viral, bacterial, and parasitic infections, thereby ensuring the health of the animal population and the integrity of research outcomes. The program is critical for compliance with federal regulations and veterinary guidelines, requiring quarterly testing of sentinel animals to maintain a specific pathogen-free environment. Interested vendors must submit their responses, including business size, capabilities, and certifications, by April 9, 2025, to Contract Officer Amy Kuczajda at amy.kuczajda@va.gov.
6550--Lab Testing Services - (HIV/HCV/HPV/On)
Buyer not available
The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
Notice of Intent to Sole Source - University of Michigan - Vaccine Cost-Effectiveness Models
Buyer not available
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price contract to the University of Michigan for access to proprietary models that assess the cost-effectiveness of vaccines. This procurement aims to secure detailed reports based on these models, which are deemed essential for the CDC's vaccine evaluation efforts, as no other models are known to provide the required level of detail. The contract will cover a base year with four additional option years, and interested parties may express their interest or capability to respond within fifteen days of this notice. Responses should be directed to contract specialists William O’Bryan at rvq0@cdc.gov and Ruben Reyes-Colon at qmz3@cdc.gov by 3:00 PM EDT on April 11, 2025.
B--Lab Services Tree Ring Research
Buyer not available
The Department of the Interior, through the United States Geological Survey (USGS), is conducting market research to identify qualified vendors for specialized laboratory services in tree-ring based paleoseismology. The procurement aims to secure dendrochronological and isotope geochemical laboratory services to support research on prehistoric earthquakes along the Cascadia Subduction Zone, including tasks such as crossdating, high-precision sample preparation, radiocarbon dating, and stable isotope analysis. These services are crucial for developing regional tree-ring chronologies that enhance understanding of seismic activity in the region. Interested vendors must demonstrate relevant experience and in-house capabilities, and are encouraged to submit their capability statements via email to Joel Berberena at jberberena@usgs.gov, adhering to the specified submission guidelines. This Request for Information (RFI) does not guarantee a contract but will inform the government's acquisition strategy.
Plasma assays of Alzheimer’s disease biomarkers (abeta42, abeta40, ptau217 ) using the Lumipulse assays on the Fujirebio G1200 in the Baltimore Longitudinal Study of Aging (BLSA)
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking a contractor to perform plasma assays of Alzheimer’s disease biomarkers (abeta42, abeta40, ptau217) using Lumipulse assays on the Fujirebio G1200 for the Baltimore Longitudinal Study of Aging (BLSA). The contractor will analyze approximately 4,000 serum/plasma samples, employing senior research specialists to ensure continuity and consistency with prior assays, ultimately contributing to the understanding of cognitive decline and Alzheimer’s disease. This procurement is critical for advancing research on early identification and treatment of Alzheimer’s and related dementias, with a contract period anticipated from May 1, 2025, to April 30, 2026. Interested parties must submit their proposals by 9:00 a.m. EDT on April 11, 2025, to Emily Palombo at emily.palombo@nih.gov.